Valuation: Carvolix

Market Cap 381M 334M 316M 288M 538M 36.5B 542M 3.78B 1.46B 18.64B 1.43B 1.4B 59.92B P/E 2026 *
-12.4x
P/E 2027 * -12.4x
Enterprise Value 416M 365M 345M 314M 588M 39.88B 592M 4.13B 1.6B 20.37B 1.56B 1.53B 65.48B EV / Sales 2026 *
285x
EV / Sales 2027 * 11.9x
Free-Float
25.49%
Yield 2026 *
-
Yield 2027 * -
1 day-1.05%
1 week-1.05%
Current month-10.19%
1 month-13.23%
3 months+71.95%
6 months+73.01%
Current year+226.01%
1 week 5.6
Extreme 5.6
5.92
1 month 5.52
Extreme 5.52
6.6
Current year 1.73
Extreme 1.73
7.56
1 year 1.32
Extreme 1.32
7.56
3 years 0.93
Extreme 0.93
7.56
5 years 0.93
Extreme 0.93
7.56
10 years 0.93
Extreme 0.93
8.6
Date Insider Type Main position Quantity % Market Cap. Importance
24/10/25
Truffle Capital SAS
BuyCompany 16,176 0.0411%
27/09/25
Truffle Capital SAS
BuyCompany 18,382 0.0467%
06/02/24
Truffle Capital SAS
BuyCompany 1,419,871 4.5955%
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%-1.05%+276.00%+412.73% 381M
-0.26%+0.41%+25.86%+29.84% 12.56B
-0.04%+2.84%+20.55%+24.53% 6.67B
+0.87%+2.81%+39.51%+23.33% 5.68B
-2.25%-8.31% - - 5.62B
-3.88%-1.65%-25.40%+32.38% 4.9B
-1.49%+0.65%-31.07%-22.46% 3.91B
-2.22%-5.09%+22.89%-8.17% 1.84B
+1.37%-1.01%-10.06%+183.65% 1.69B
-0.33%+1.16%+48.56%-13.35% 1.59B
Average -0.93%-0.92%+40.76%+73.61% 4.48B
Weighted average by Cap. -0.86%-0.49%+16.51%+29.89%

Financials

2026 *2027 *
Net sales 1.46M 1.28M 1.21M 1.1M 2.06M 140M 2.08M 14.47M 5.61M 71.46M 5.48M 5.36M 230M 37.92M 33.27M 31.42M 28.64M 53.61M 3.63B 53.99M 376M 146M 1.86B 142M 139M 5.97B
Net income -37.3M -32.73M -30.91M -28.17M -52.73M -3.57B -53.11M -370M -143M -1.83B -140M -137M -5.87B -11.56M -10.14M -9.58M -8.73M -16.34M -1.11B -16.46M -115M -44.4M -566M -43.4M -42.46M -1.82B
Net Debt 35.3M 30.97M 29.25M 26.66M 49.91M 3.38B 50.26M 350M 136M 1.73B 133M 130M 5.55B 69.56M 61.04M 57.65M 52.54M 98.35M 6.67B 99.05M 690M 267M 3.41B 261M 256M 10.95B
Logo Carvolix
Carvolix (formerly Affluent Medical) specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Employees
59
Date Price Change Volume
25/09/26 €5.640 -1.05% 8,195
24/09/26 €5.700 -2.06% 9,644
23/09/26 €5.820 +2.83% 30,555
22/09/26 €5.660 -0.70% 13,344
21/09/26 €5.700 0.00% 12,976
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.640EUR
Average target price
8.775EUR
Spread / Average Target
+55.59%

Annual profits - Rate of surprise